Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy. Its mission is to improve freedom and independence for oxygen therapy patients through innovative products and services. The Company's compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. As a manufacturer and Accredited Homecare Provider dedicated to oxygen therapy, Inogen is ideally suited to develop products tailored to oxygen therapy users and to provide superior service to those users in their homes. 

Company Growth (employees)
Goleta, US
Size (employees)
602 (est)
Inogen was founded in 2001 and is headquartered in Goleta, US

Key People/Management at Inogen

Raymond Huggenberger

Raymond Huggenberger

Member of the Board of Directors

Inogen Office Locations

Inogen has offices in Goleta, Ventura, Santa Barbara, Aurora and in 13 other locations
Goleta, US (HQ)
326 Bollay Dr
Show all (17)

Inogen Financials and Metrics

Inogen Financials

Inogen's revenue was reported to be $202.8 m in FY, 2016

Revenue (Q3, 2017)

69 m

Gross profit (Q3, 2017)

33.2 m

Gross profit margin (Q3, 2017), %


Net income (Q3, 2017)

7.3 m

EBIT (Q3, 2017)

8.3 m

Market capitalization (13-Nov-2017)

2.6 b

Cash (30-Sep-2017)

129.7 m
Inogen's current market capitalization is $2.6 b.
USDFY, 2014FY, 2015FY, 2016


112.5 m159 m202.8 m

Revenue growth, %


Cost of goods sold

57 m82.7 m

Gross profit

55.5 m76.3 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


23.6 m30.4 m29.4 m33.8 m44 m40.8 m64.1 m69 m

Cost of goods sold

11.7 m15.3 m14.7 m17.7 m23.2 m21.4 m32.6 m35.9 m

Gross profit

11.9 m15.1 m14.6 m16 m20.8 m19.4 m31.6 m33.2 m

Gross profit Margin, %

USDFY, 2014FY, 2015FY, 2016


56.8 m66.1 m92.9 m

Accounts Receivable

30.8 m


1.1 m870 k1.7 m

Current Assets

92.5 m114.8 m161.5 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


59.6 m69 m56.2 m61.1 m51.8 m55.1 m72.4 m84.5 m86 m105.1 m114.7 m129.7 m

Accounts Receivable

23.7 m27.8 m29.7 m30.9 m34.8 m34.7 m


10.3 m12.5 m16.5 m14 m15.9 m3.2 m

Current Assets

87.5 m97.7 m89.3 m100.5 m109.4 m114.4 m124 m142.6 m158.1 m176.5 m198.8 m219.8 m
    USDFY, 2014FY, 2015FY, 2016

    Net Income

    6.8 m11.6 m20.5 m

    Depreciation and Amortization

    12.1 m14 m13.6 m

    Accounts Receivable

    (22.2 m)(16.7 m)(32.7 m)


    (3.6 m)(2.6 m)(7.5 m)
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Net Income

    888 k3.2 m5.3 m1.6 m5 m7.7 m2.4 m7.5 m11 m5.9 m14.3 m7.3 m

    Depreciation and Amortization

    2.7 m5.6 m8.8 m3.4 m6.9 m10.5 m3.4 m6.9 m10.3 m3.2 m6.3 m

    Accounts Receivable

    (10.7 m)(10.6 m)(17.1 m)(6.2 m)(12.1 m)(13.3 m)(9.5 m)(18.4 m)(25.8 m)(5 m)(12.4 m)34.7 m


    (429 k)(1.9 m)(3.2 m)(199 k)(1.8 m)(3.2 m)(2.2 m)(5 m)(9.2 m)49 k(2.2 m)3.2 m
      Y, 2017

      Financial Leverage

      1.2 x
      Show all financial metrics

      Inogen Market Value History

      Inogen's Web-traffic and Trends

      Inogen Online and Social Media Presence

      Inogen News and Updates

      Medical Oxygen Systems Market Worth US$ 4 Bn Between 2016 to 2024

      Persistence Market Research has announced the addition of the “Global Market Study on Medical Oxygen Systems: Liquid Oxygen Systems Product Type Segment to Witness Sustained Growth in the Latter Half of the Forecast Period" report to their offering. Posted via Industry Today. Follow us on Twitter @I…

      Raymond Huggenberger, Former Inogen CEO, Joins Clarify Medical Board of Directors

      PRESS RELEASE: Clarify Medical Inc. today announced that Raymond Huggenberger had been elected a member of the company's Board of Directors, effective immediately. "We are delighted to have Ray as a member of the Board," said David Hale,...

      Inogen Company Life and Culture

      You may also be interested in